While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
In July, the company received $176 million from HHS toward its vaccine efforts. Moderna plans to advance research on the ...
The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback